Which companies discussed AI Inference Demand in Health Care in earnings calls?

110 companies mentioned ai inference demand across 133 earnings calls in Health Care over the past year, spanning 1 sectors. The most active were Exelixis, Inc. (5 calls), Revolution Medicines, Inc. (5 calls), Moderna, Inc. (3 calls). The table below ranks every company by how often the theme came up, with direct links to each transcript.

Mentions over time

Data table
QuarterCalls mentioning AI Inference Demand
2024Q312
2024Q425
2025Q133
2025Q213
2025Q323
2025Q430
2026Q137
2026Q240
2026Q316

Companies ranked by mentions

Company Ticker Sector Calls Last mention
Exelixis, Inc. EXEL Health Care 5 Jun 9, 2026
Revolution Medicines, Inc. RVMD Health Care 5 May 31, 2026
Moderna, Inc. MRNA Health Care 3 Jun 1, 2026
Imricor Medical Systems, Inc. IMR Health Care 2 Aug 9, 2026
Novo Nordisk A/S NOVOB Health Care 2 Aug 5, 2026
Summit Therapeutics Inc. SMMT Health Care 2 Jun 1, 2026
Protara Therapeutics, Inc. TARA Health Care 2 May 19, 2026
Alignment Healthcare, Inc. ALHC Health Care 2 May 13, 2026
Astrana Health, Inc. ASTH Health Care 2 May 7, 2026
GeneDx Holdings Corp. WGS Health Care 2 May 4, 2026
Alnylam Pharmaceuticals, Inc. ALNY Health Care 2 Apr 30, 2026
Ocular Therapeutix, Inc. OCUL Health Care 2 Mar 2, 2026
Denali Therapeutics Inc. DNLI Health Care 2 Feb 5, 2026
Absci Corporation ABSI Health Care 2 Jan 14, 2026
Vera Therapeutics, Inc. VERA Health Care 2 Jan 13, 2026
Arcellx, Inc. ACLX Health Care 2 Dec 7, 2025
MediWound Ltd. MDWD Health Care 1 Aug 13, 2026
cbdMD, Inc. YCBD Health Care 1 Aug 13, 2026
Nutex Health Inc. NUTX Health Care 1 Aug 7, 2026
Progyny, Inc. PGNY Health Care 1 Aug 6, 2026
Lexicon Pharmaceuticals, Inc. LXRX Health Care 1 Aug 6, 2026
INmune Bio Inc. INMB Health Care 1 Aug 6, 2026
Recursion Pharmaceuticals, Inc. RXRX Health Care 1 Aug 5, 2026
ICON Public Limited Company ICLR Health Care 1 Jul 30, 2026
Guardant Health, Inc. GH Health Care 1 Jul 30, 2026
Illumina, Inc. ILMN Health Care 1 Jul 30, 2026
Beta Bionics, Inc. BBNX Health Care 1 Jul 29, 2026
NovoCure Limited NVCR Health Care 1 Jul 23, 2026
bioAffinity Technologies, Inc. BIAF Health Care 1 Jul 21, 2026
Fractyl Health, Inc. GUTS Health Care 1 Jul 15, 2026
ABIVAX Société Anonyme ABVX Health Care 1 Jun 29, 2026
Hansa Biopharma AB (publ) HNSA Health Care 1 Jun 25, 2026
Enliven Therapeutics, Inc. ELVN Health Care 1 Jun 11, 2026
Maze Therapeutics, Inc. MAZE Health Care 1 Jun 10, 2026
Spectral Medical Inc. EDT Health Care 1 Jun 8, 2026
QMS Medical Allied Services Limited QMSMEDI Health Care 1 Jun 4, 2026
Poly Medicure Limited 531768 Health Care 1 May 25, 2026
Twist Bioscience Corporation TWST Health Care 1 May 21, 2026
ZIM Laboratories Limited 541400 Health Care 1 May 20, 2026
dorsaVi Ltd DVL Health Care 1 May 20, 2026
Axe Compute Inc. AGPU Health Care 1 May 18, 2026
Design Therapeutics, Inc. DSGN Health Care 1 May 18, 2026
Lucid Diagnostics Inc. LUCD Health Care 1 May 14, 2026
Invivyd, Inc. IVVD Health Care 1 May 14, 2026
CeriBell, Inc. CBLL Health Care 1 May 13, 2026
Humacyte, Inc. HUMA Health Care 1 May 13, 2026
Thyrocare Technologies Limited 539871 Health Care 1 May 12, 2026
Lantheus Holdings, Inc. LNTH Health Care 1 May 7, 2026
Harmony Biosciences Holdings, Inc. HRMY Health Care 1 May 7, 2026
10x Genomics, Inc. TXG Health Care 1 May 7, 2026

Representative quotes

…regulatory development side. And so my final question is, from a product strategy standpoint and a marketing spend standpoint, Is it fair to infer that you intend to be fairly cautious on major new marketing initiatives and product launches until you'll get much better federal regulatory clarity…
cbdMD, Inc. (YCBD), August 13, 2026. Read the full transcript →
…that mean that since SANTYL is not particularly effective and that Smith & Nephew is motivated to create a new drug, this must -- the inference is that the market is even bigger than what SANTYL is currently supplying. And we believe the answer to that is resoundingly yes. That…
MediWound Ltd. (MDWD), August 13, 2026. Read the full transcript →
…step back for a moment and remind everyone what this is all for, because the essence of Imricor fits into 4 words: from inferring to visualizing. X-ray cath labs have carried this field for decades. They've enabled tremendous advances in cardiac care, but they have…
Imricor Medical Systems, Inc. (IMR), August 9, 2026. Read the full transcript →
…fair federal dispute resolution system. In fact, in the Georgia ruling that George stated and I quote, it is highly improbable to infer from these facts that there is a vast conspiracy of providers and IDRs that have conspired to defraud the plaintiff of millions of dollars…
Nutex Health Inc. (NUTX), August 7, 2026. Read the full transcript →

Frequently asked questions

What is AI Inference Demand and why are companies discussing it?

The compute spend that follows AI deployment — distinct from training. Critical for chips, networking and cloud economics.

Which company mentioned ai inference demand most in Health Care in the past year?

Exelixis, Inc. (EXEL) led with 5 calls referencing ai inference demand, most recently on June 9, 2026.

How can I track ai inference demand mentions across earnings calls via API?

The EarningsCalls.dev REST API exposes the same data behind this page. Use the search_transcripts and count_mentions_by_ticker endpoints to query our archive of 33,000+ earnings call transcripts — keyword search, sector / date filters, per-company mention counts, and the underlying full transcripts. See the API docs →

Related technology themes

Last updated: August 14, 2026. Methodology: full-text search across all earnings call transcripts in our corpus over the past 12 months, matching the canonical term and its aliases (inference, inference). Mentions are per call, not per occurrence within a call; the company-rank table is built by counting distinct calls mentioning the theme. Page refreshes every hour at the edge as new calls land in our archive.